1. Home
  2. VTGN

as 12-18-2024 10:44am EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.

Founded: 1998 Country:
United States
United States
Employees: N/A City: SOUTH SAN FRANCISCO
Market Cap: 72.4M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 198.6K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.31 EPS Growth: N/A
52 Week Low/High: $2.38 - $5.86 Next Earning Date: 02-11-2025
Revenue: $876,000 Revenue Growth: 8.08%
Revenue Growth (this year): -33.95% Revenue Growth (next year): -39.04%

VTGN Daily Stock ML Predictions

Share on Social Networks: